Federica Nardi

Federica Nardi graduated in Molecular and Cellular Biology in 2014 at the University of Siena. In 2018, she obtained her PhD in Biochemistry and Molecular Biology under the guidance of Prof. Maurizio Orlandini. During her PhD she worked on the characterisation of proteins involved in angiogenesis, in particular the surface protein CD93. Before completing her PhD, she worked for six months at Professor Dario Neri’s laboratories at PHILOCHEM where she selected antibodies against tumour antigens using phage display technology. After her PhD she worked at the Aviano cancer reference centre, where she dedicated herself to the study of the mechanisms that drive the development and progression of gastrointestinal stromal tumours, gaining experience with RNA-seq and data analysis. She then worked as a post-doc at the University of Modena and Reggio Emilia in a project on retinitis pigmentosa, a genetic eye disease leading to retinal degeneration and blindness. She recently moved to Toscana Life Sciences and works in Dr. Anna Kabanova’s group. At TLS she is working in a project funded by AIRC and is studying the tumour suppression mechanisms adopted by B cells in chronic lymphatic leukaemia (CLL)